"Evo 2" .. Has artificial intelligence uncovered the code of life?

A team of researchers, funded by the "Ark Institute," has made a significant scientific leap by developing a unique artificial intelligence model named "Evo 2," which integrates the genomes of over 128,000 living species in a massive database hosted by "Amazon Web Services."

This advanced model was developed in collaboration with the technology giant "NVIDIA," utilizing around 2000 H100 chips, the company's flagship product.

This innovation aims to accelerate research on complex human diseases, as confirmed by Sylvana Conrman, director of the "Ark Institute."

"Evo 2" assists scientists in understanding genetic mutations linked to diseases, enabling the precise design of new therapeutic molecules targeting these mutations, according to a statement from "NVIDIA."

The project includes elite researchers from Stanford, Berkeley, and San Francisco universities in California.

In tests conducted on a gene associated with breast cancer, "Evo 2" was able to accurately identify benign and disease-causing mutations with a precision of 90%, according to a report from the "Ark Institute."

In addition to medical applications, "Evo 2" holds promising potential in biotechnology, where it can be used to develop plants more resistant to climate change and richer in nutrients. It can also be utilized in designing enzymes capable of breaking down plastic, paving the way for innovative environmental solutions.

With this innovation, artificial intelligence enters a new phase, where its role is not limited to analysis and prediction but becomes a fundamental partner in the development of medical treatments and biological technologies, potentially reshaping the future of medicine and biological sciences.